KNCV Publications

Overview of KNCV Publications by year

Publications 2024

Publications 2023

Publications 2022

  • Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, G. White, Bakker R et al. The impact of alternative delivery strategies for novel tuberculosis vaccines in low- and middle-income countries: a modelling study. medRxiv 2022. Abstract
  • Portnoy A, Clark RA, Quaife M, Weerasuriya CK, Bakker R et al. The cost and cost- effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modelling study. medRxiv 2022. Abstract
  • Portnoy A, Arcand JL, Clark RA, Chathika K, Bakker R et al. The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries. medRxiv 2022. Abstract
  • Mengesha MM, Gebremichael MA, Watumo D, Hallström IK, Jerene D (2022) Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: An institution-based cross-sectional study. PLOS Glob Public Health 2(3) 2022. Abstract
  • Tefera Belachew Agizew, Zewdu Gashu Dememew, Taye Leta, Nebiyu Hiruy, Emawayish Tesema, Degu Jerene et al. Prospects for tuberculosis elimination in Ethiopia: feasibility, challenges, and opportunities. Pan African Medical Journal. 2022;43:146. Abstract
  • Mengesha MM, Gebremichael MA, Watumo D, Hallström IK, Jerene D. Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: An institution-based cross-sectional study. PLOS Glob Public Health 2022;2(3). Abstract
  • de Haas P, Yenew B, Diriba G, Tiemersma EW, Slyzkyi A, Demissie Y et al. The Simple One-step stool processing method for detection of Pulmonary tuberculosis: A study protocol to assess the robustness, stool storage conditions and sampling strategy for global implementation and scale-up. PLoS One. 2022;17(10). Abstract
  • Nicole Salazar-Austi, Christiaan Mulder, Graeme Hoddinott, Theresa Ryckman, Colleen F. Hanrahan, Kavindhran Velen, Lucy Chimoyi, Salome Charalambous and Violet N Chihota. Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients. Pathogens 2022, 11(11), 1258; Abstract & full paper.
  • Degu Jerene, Dawid Assefa, Kalkidan Tesfaye, Samuel Bayu, Samuel Seid, Fikirte Aberra, Ahmed Bedru, et al. Effectiveness of women-led community interventions in improving tuberculosis preventive treatment in children: results from a comparative, before–after study in Ethiopia. BMJ Open 2022;12:e062298. doi:10.1136/ bmjopen-2022-062298. Full paper.
  • Christiaan Mulder, Stephan Rupert, Ery Setiawan, Elmira Mambetova, Patience Edo, Jhon Sugiharto, Sani Useni, et al. Budgetary impact of using BPaL for treating extensively drug- resistant tuberculosis. BMJ Global Health 2022;7:e007182. doi:10.1136/ bmjgh-2021-007182. Full paper

Publications 2021

  • Gronholm PC, Nosé M, van Brakel WH, Eaton J, Fiekert K et al. Reducing stigma and discrimination associated with COVID-19: early stage pandemic rapid review and practical recommendations. Epidemiol Psychiatr Sci. 2021 Jan 28;30:e15. Abstract
  • Gronholm PC, Nosé M, van Brakel WH, Eaton J, Fiekert K et al. Reducing stigma and discrimination associated with COVID-19: early stage pandemic rapid review and practical recommendations. Epidemiol Psychiatr Sci. 2021 Jan 28;30:e15. Abstract
  • Mitchell EMH, Adejumo OA, Abdur-Razza H, Ogbudebe C, Gidado M et al. Hybrid Approach to Estimation of Underreporting of Tuberculosis Case Notification in High- Burden Settings With Weak Surveillance Infrastructure: Design and Implementation of an Inventory Study. JMIR Public Health Surveill 2021 (7)| iss. 3 | e22352. Abstract
  • Tadesse BT, Foster BA, Latour E, Lim JY, Jerene D et al. Predictors of Virologic Failure Among a Cohort of HIV-infected Children in Southern Ethiopia. Pediatr Infect Dis J. 2021 Jan;40(1):60-65. Abstract
  • Gurung SC, Rai B, Dixit K, Levy JW, van Rest J et al. How to reduce household costs for people with tuberculosis: a longitudinal costing survey in Nepal. Health Policy Plan. 2021 Jun 3;36(5):594-605. Abstract
  • McQuaid CF, Vassall A, Cohen T, Fiekert K, White RG et al. The impact of COVID-19 on TB: a review of the data. Int J Tuberc Lung Dis. 2021 Jun 1;25(6):436-446. Abstract
  • de Vries G, van de Berg S, van Dam A, Hasanova S, Pareek M et al. Collaborative tuberculosis/HIV activities in the European Region. ERJ Open Res. 2021 Jan 18;7(1):00721- 2020. Abstract
  • Lyakurwa D, Lyimo J, Mulder C, Pelzer PT, Koppelaar I et al. Assessment of training and mentoring for DR-TB care decentralization in Tanzania. Hum Resour Health. 2021 Apr 26;19(1):56. Abstract
  • Jerene D, Tiberg I, Hallström I. How Can Clinical Outcomes among Adolescents Living with HIV in Ethiopia be Improved? Healthcare Professionals’ Perspectives. Compr Child Adolesc Nurs. 2021 May 7:1-10. Abstract
  • de Haas P, Yenew B, Mengesha E, Slyzkyi A, Gashu Z et al. The Simple One-Step (SOS) stool processing method for use with the Xpert MTB/RIF assay for a child-friendly diagnosis of tuberculosis closer to the point-of-care. J Clin Microbiol. 2021 Jun 2. Abstract
  • McQuaid CF, Foster N, Quaife M, Levy J, Tadesse AW et al. Digital adherence technology for TB: focus on livelihoods as well as lives. Int J Tuberc Lung Dis. 2021 May 1;25(5):416-417. No abstract available.
  • de Vries G, Gainaru D, Keizer S, Mahler B, Radulescu I et al. Human reading versus computer automated reading of chest X-rays in a tuberculosis screening programme in Romania. Eur Respir J. 2021 Mar 10:2004628. No abstract available.
  • Gurung SC, Dixit K, Rai B, Paudel PR, Levy JW et al.. Comparative Yield of Tuberculosis during Active Case Finding Using GeneXpert or Smear Microscopy for Diagnostic Testing in Nepal: A Cross-Sectional Study. Trop Med Infect Dis. 2021 Apr 14;6(2):50. Abstract
  • Tesema E, Wares F, Bedru A, Negeri C, Molla Y, et al. Experiences of introducing new drugs for drug-resistant TB at the ALERT Hospital, Addis Ababa, Ethiopia, 2017–2019. Public Health Action 2021 June; 11(2): 50–52. Full paper
  • Monedero-Recuero I, Gegia M, Wares F, Chadha S, Mirzayev F. Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape. IJID 2021;108: 557–567. Full paper
  • Ragonnet R, Flegg JA, Brilleman SL, Tiemersma EW, Melsew YA et all. Revisiting the Natural History of Pulmonary Tuberculosis: A Bayesian Estimation of Natural Recovery and Mortality RatesRates. Clin Infect Dis. 2021 Jul 1;73(1). Abstract
  • Shiferaw MB, Amare D, Alem G, Asefa D, Klinkenberg E et al. Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia. PLoS One 2021 Jun 11;16(6). Abstract
  • Churchyard G, Cárdenas V, Chihota V, Mngadi K, van den Hof S et al. Annual Tuberculosis. Suliman S, Pelzer PT, Shaku M, Rozot V, Mendelsohn SC. Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021. Abstract
  • Spruijt I, Joren C, van den Hof S, Erkens C et al. Tailored approaches facilitate high completion of tuberculosis infection treatment among migrants. Eur Respir J 2021. Preventive Therapy for Persons With HIV Infection: A Randomized Trial. Aug 24. Abstract
  • Charlie L, Saidi B, Getachew E, Wanjiru CL, Abebe M et al. RN Programmatic challenges in managing multidrug-resistant tuberculosis in Malawi. Int J Mycobacteriol. 2021 Jul- Sep;10(3):255-259. Abstract
  • van de Berg SEJ, Pelzer PT, van der Land AJ, Abdrakhmanova E, Ozi AM et al. Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients. BMC Public Health. 2021 Jul 16;21(1):1404. Abstract
  • Dixit K, Biermann O, Rai B, Aryal TP, Paudel PR et al. Barriers and facilitators to accessing tuberculosis care in Nepal: a qualitative study to inform the design of a socioeconomic support intervention. BMJ Open. 2021 Oct 1;11(10). Abstract
  • Mehra N, Tunje A, Hallström IK, Jerene D. Effectiveness of mobile phone text message reminder interventions to improve adherence to antiretroviral therapy among adolescents living with HIV: A systematic review and meta-analysis. PLoS One. 2021 Jul 22;16(7). Abstract
  • Mahler B, de Vries G, van Hest R, Gainaru D, Menezes D, Popescu G, Story A, Abubakar I. Use of targeted mobile X-ray screening and computer-aided detection software to identify tuberculosis among high-risk groups in Romania: descriptive results of the E-DETECT TB active case-finding project. BMJ Open. 2021 Aug 24;11(8). Abstract
  • Ngoc NB, Vu Dinh H, Thuy NT, Quang DV, Tiemersma E et al. Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam. PLoS One. 2021 Sep 7;16(9). Abstract
  • Conroy O, Wurie F, Collin SM, Edmunds M, de Vries G et al. Barriers and enablers to implementing tuberculosis control strategies in EU and European Economic Area countries: a systematic review. Lancet Infect Dis. 2021 Sep;21(9):e272-e280. Abstract
  • Van de Berg SEJ, Erkens C, Mulder C. Tuberculosis contact investigation following the stone-in-the-pond principle in the Netherlands – Did adjusted guidelines lead to improved efficiency?. Eurosurveillance 2021. Accepted for publication.
  • Dixit K, Biermann O, Levy J, van Rest J, Chandra Gurung S et al. Barriers and facilitators to accessing tuberculosis care in Nepal: a qualitative study to inform the design of a socioeconomic support intervention. BMJ. 2021 Oct 1;11(10). Abstract
  • Sara Suliman, Puck T. Pelzer, Moagi Shakua, Virginie Rozot, Simon C. Mendelsohn; Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2020. ScienceDirect. 2021, September 15; S0264-410X(21)01154-3. Full article/abstract.
  • Tesema E, Wares F, Bedru A, Negeri C, Molla Y, Gemechu D, Kassa A, Tsegaye F, Taye L.; Experiences of introducing new drugs for drug-resistant TB at the ALERT Hospital, Addis Ababa, Ethiopia. 2017-2019; Public Health Action. 2021 Jun 21;11(2):50-52. Abstract.
  • Shiferaw MB, Sinishaw MA, Amare D, Alem G, Asefa D, Klinkenberg E.; Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia; PLoS One. 2021 Jun 11;16(6):e0253177. Abstract/full article.
  • Gurung SC, Dixit K, Rai B, Dhital R, Paudel PR, Acharya S, Budhathoki G, Malla D, Levy JW, et al.’ Comparative Yield of Tuberculosis during Active Case Finding Using GeneXpert or Smear Microscopy for Diagnostic Testing in Nepal: A Cross-Sectional Study; Trop Med Infect Dis. 2021 Apr 14;6(2):50. Abstract.
  • Lyakurwa D, Lyimo J, Mulder C, Pelzer PT, Koppelaar I, Heus M.; Assessment of training and mentoring for DR-TB care decentralization in Tanzania; Hum Resour Health. 2021 Apr 26;19(1):56. Abstract/full article.
  • Gurung SC, Rai B, Dixit K, Worrall E, Paudel PR, Dhital R, Sah MK, Pandit RN, at al. How to reduce household costs for people with tuberculosis: a longitudinal costing survey in Nepal; Health Policy Plan. 2021 Jun 3;36(5):594-605. Abstract/full article.
  • Petra de Haas, Bazezew Yenewb, Endale Mengeshac, Andrii Slyzkyia, Zewdu Gash, et al. The Simple One-Step (SOS) Stool Processing Method for Use with the Xpert MTB/RIF Assay for a Child-Friendly Diagnosis of Tuberculosis Closer to the Point of Care. Journal of Clinical Microbiology, 2021, JCM. 00406-21. Abstract.
  • Van de Berg S.E.J., Pelzer P.T., van der Land A.J., Abdrakhmanova E. et al. Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients. BMC Public Health. 2021 July 16;21:1404. Full article.

Publications 2020

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.